Gyre Therapeutics, Inc. · NASDAQ:GYRE

Gyre Therapeutics, Inc. financial statements

Gyre Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue116.6M105.8M113.5M102.3M7.34M20.9M6.00K1.02M
Cost of revenue5.42M3.88M4.64M4.79M
Gross profit111.2M101.9M108.8M97.5M
Research and development13.7M12.0M13.8M16.7M68.9M53.0M43.9M21.5M12.8M11.6M
Operating income11.5M16.2M-67.2M9.20M-87.9M-57.4M-57.3M-33.8M-21.8M-20.4M
Depreciation and amortization2.48M1.55M1.07M1.09M290.0K138.0K146.0K149.0K173.0K389.0K
EBITDA14.0M17.7M-66.2M10.3M-87.6M-57.2M-57.1M-33.7M-21.6M-20.0M
Income before tax14.4M23.2M-77.0M9.41M-87.9M
Income tax4.56M5.32M8.52M5.10M
Net income9.88M17.9M-85.5M4.31M-87.9M-56.2M-55.2M-30.1M-21.6M-16.9M
Earnings per share, basic0.060.14-1.410.04-2.87-2.93-4.60-2.68-7.45-21.75
Earnings per share, diluted0.020.05-1.410.03-2.87-2.93-4.60-2.68-7.45-21.75

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents49.2M11.8M33.5M25.2M44.3M30.4M15.4M31.2M14.5M10.3M
Short-term investments15.4M14.9M02.50M49.0M61.5M88.9M18.0M6.80M
Receivables31.1M19.6M15.2M1.82M3.31M15.0M
Inventory10.2M6.34M4.28M6.12M
Current assets149.4M64.8M57.2M49.7M51.5M89.5M96.1M124.0M39.1M37.5M
Property, plant and equipment27.5M23.9M23.3M17.7M970.0K433.0K304.0K386.0K276.0K444.0K
Total assets219.8M125.4M116.5M84.8M55.7M94.8M98.6M124.9M39.5M38.1M
Accounts payable1.33M108.0K355.0K122.0K6.42M5.93M4.28M1.25M747.0K837.0K
Current liabilities23.8M19.5M20.0M12.2M14.2M17.8M28.9M4.80M8.74M22.0M
Total liabilities31.4M27.0M38.1M12.5M14.6M18.8M30.2M4.97M8.74M22.0M
Shareholders' equity62.5M63.3M-15.8M42.5M41.1M76.1M68.3M119.9M30.8M16.1M
Shares outstanding91.3M86.3M76.6M63.6M31.4M22.1M12.0M12.0M6.08M801.8K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations1.01M-3.64M25.9M10.7M-83.8M-55.0M-43.6M-28.6M-19.9M-18.5M
Capital spending-1.19M-2.31M-8.52M-4.99M-839.0K-64.0K-376.0K-23.0K-468.0K
Free cash flow-180.0K-5.96M17.4M5.69M-84.6M-43.7M-28.9M-20.0M-18.9M
Cash from investing-474.0K-19.9M-19.8M-13.8M48.2M9.66M27.4M-71.3M-11.2M-1.31M
Cash from financing24.4M2.10M2.50M-45.0M49.6M60.4M327.0K111.3M21.1M948.0K
Dividends paid-45.0M
Change in cash25.3M-21.7M8.33M-5.03M14.0M15.0M-15.9M11.5M-10.1M-18.8M